{"nctId":"NCT04426500","briefTitle":"Use of Perioperative Pain Blocks In Urological Surgery","startDateStruct":{"date":"2019-11-11","type":"ACTUAL"},"conditions":["Pain, Postoperative","Nerve Block","Robotic Surgical Procedures"],"count":148,"armGroups":[{"label":"Placebo/Local Anesthesia","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Bupivacain"]},{"label":"Ultrasound-guided transversus abdominus plane (UTAP) block","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Bupivacain","Drug: Ultrasound-guided transversus abdominus plane block"]},{"label":"Laparoscopic-guided transversus abdominus plane (LTAP) block","type":"EXPERIMENTAL","interventionNames":["Drug: Bupivacain","Drug: Laparoscopic-guided transversus abdominus plane block"]}],"interventions":[{"name":"Bupivacain","otherNames":["Local anesthesia"]},{"name":"Ultrasound-guided transversus abdominus plane block","otherNames":["UTAP"]},{"name":"Laparoscopic-guided transversus abdominus plane block","otherNames":["LTAP"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 18 years or older\n* Undergoing Robotic Assisted Laparoscopic Partial Nephrectomy or Robotic Assisted Laparoscopic Prostatectomy\n* Ability to understand and the willingness to sign a written informed consent.\n\nExclusion Criteria:\n\n* Prior Partial Nephrectomy or Subtotal Prostatectomy Surgery (organ specific)\n* Conversion to open surgery\n* History of chronic pain\n* History of opiate or alcohol dependence\n* Allergies to local anesthetic\n* Retroperitoneal surgery\n* Single Port Surgery","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Visual Analog Scale (VAS)","description":"Visual analog scale (VAS) is a pain rating scale, with full scale from 0 to 10, higher score indicating more pain","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.29","spread":"1.98"},{"groupId":"OG001","value":"3.16","spread":"3.10"},{"groupId":"OG002","value":"2.89","spread":"2.69"}]}]}]},{"type":"SECONDARY","title":"Intraoperative Time and Block Time","description":"Intraoperative time taken to complete surgical blocks and operative","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":null},{"groupId":"OG001","value":"6.0","spread":null},{"groupId":"OG002","value":"2.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"211.5","spread":null},{"groupId":"OG001","value":"224.5","spread":null},{"groupId":"OG002","value":"221","spread":null}]}]}]},{"type":"SECONDARY","title":"Intraoperative Narcotic Use","description":"Intraoperative Narcotic Use in morphine equivalents","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27.0","spread":"12.6"},{"groupId":"OG001","value":"24.1","spread":"12.64"},{"groupId":"OG002","value":"25.5","spread":"15.2"}]}]}]},{"type":"SECONDARY","title":"Intraoperative Ketoralac Use","description":"Intraoperative Ketoralac Use","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"15","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Narcotic Use","description":"Postoperative Narcotic Use in morphine equivalents","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.13","spread":null},{"groupId":"OG001","value":"19.50","spread":null},{"groupId":"OG002","value":"17","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Analgesic Medications","description":"The 24-hour cumulative postoperative opioid analgesic requirement was calculated using standard tables to morphine equivalents.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1650","spread":null},{"groupId":"OG001","value":"1650","spread":null},{"groupId":"OG002","value":"1325","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"30","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"The Amount of Ondansetron Use","description":"Use of antiemetic medications during the postoperative course","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.19"},{"groupId":"OG001","value":"0.31","spread":"1.30"},{"groupId":"OG002","value":"0.29","spread":"1.29"}]}]}]},{"type":"SECONDARY","title":"Number of Days to Return of Bowel Function","description":"Number of days to the return of bowel function","classes":[]},{"type":"SECONDARY","title":"The Length of Hospital Stay","description":"Length of hospital stay from time of surgical completion to time of discharge.","classes":[]},{"type":"SECONDARY","title":"VAS in Obese Patients","description":"24 hour postoperative pain scores recorded using the visual analog scale (VAS) in obese patients. Visual analog scale (VAS) is a pain rating scale, with full scale from 0 to 10, higher score indicating more pain. Comparison in patients with BMI \\>30 and BMI\\<30","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.29","spread":"2.21"},{"groupId":"OG001","value":"4.09","spread":"2.94"},{"groupId":"OG002","value":"2.33","spread":"2.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.29","spread":"1.95"},{"groupId":"OG001","value":"2.67","spread":"3.11"},{"groupId":"OG002","value":"3.00","spread":"2.75"}]}]}]},{"type":"SECONDARY","title":"Number of Procedure Related Complications","description":"Procedure related complications and adverse events including bleeding or injection of anesthetic intravascular was determined according to Common Terminology Criteria for Adverse Events (CTCAE v 4.0).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":28},"commonTop":[]}}}